SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-22
👔
Cardiff Oncology, Inc.
@CRDF_InsiderForm 4 Filing: Mohindru Mani Buys $29,890.63 of $CRDF
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Cardiff Oncology, Inc.
Ticker: $CRDF
Transaction Value
$29,890.63
Price/Share: $1.21
transaction date
2026-06-18
Shares: 24,703
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Mohindru Mani, holds the title of Chief Executive Officer at Cardiff Oncology, Inc..
On 2026-06-18, the insider transacted 24,703 shares.The shares were transacted at a weighted average price of $1.21 per share, resulting in a total market-relevant value of $29,890.63.
Executive Summary Summary
Mohindru Mani (Chief Executive Officer) bought $30K of $CRDF
Post-Transaction Position: 24,703 shares
SEC Accession No: 0001664708-26-000002 (CIK: 1664708)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.